Prostate cancer is a common male cancer and although it is usually slow growing, aggressive forms have also been found. Because prostate cancer affects so many men and causes such devastation, there are always new drugs and treatments being studied in hopes of finding a cure. One of the most common types of treatment given to men who have been diagnosed with prostate cancer is hormone therapy, which is usually long term.
The purpose of the hormone therapy is to reduce the amount of male hormones in the body and hopefully slow or even stop the growth of the cancer. A recent study found that long term hormone therapy really had no more benefits than short term hormone therapy.
The results of men who had received both long term hormone therapy and short term therapy were analyzed and showed that there was no significant difference in the results. Hormone therapy cannot cure prostate cancer, but both types of therapy were able to slow down the growth of tumors on the prostate.
The results of this analysis were presented at the American Society for Radiation Oncology's 55th Annual Meeting. More than 11,000 people attended this meeting, which took place in Atlanta. Oncologists, doctors, radiation therapists and other types of healthcare workers all attend this meeting in order to learn about new treatment plans, medications and share stores and information. The meeting lasts for four days and includes guest speakers, presentations, posters and workshops.
Although there is currently no cure for prostate cancer, meetings like this improve the possibility of finding a cure. Each meeting has a theme and main focus. The 2013 meeting’s theme was "Patients: Hope • Guide • Heal" and the main focus of the meeting was how to improve patient care and make them more comfortable.
Image from Wikimedia Commons.